On December 22, 2022, Gary Cantrell, a member of the Board of Directors of Aytu BioPharma, Inc., notified the Company of his intention to retire from the Company's Board of Directors, effective December 31, 2022. Mr. Cantrell did not advise the Company of any disagreement with the Company on any matter relating to its operations, policies or practices. The Company is initiating a search for an additional member of the Board of Directors.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.2 USD | +0.95% | +5.56% | +12.68% |
05-15 | Transcript : Aytu BioPharma, Inc., Q3 2024 Earnings Call, May 15, 2024 | |
05-15 | Aytu BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.68% | 17.65M | |
+43.08% | 750B | |
+34.11% | 606B | |
-6.81% | 356B | |
+19.08% | 326B | |
+6.56% | 286B | |
+18.08% | 246B | |
-3.44% | 213B | |
+11.35% | 213B | |
+2.48% | 167B |
- Stock Market
- Equities
- AYTU Stock
- News Aytu BioPharma, Inc.
- Gary Cantrell to Retire from the Aytu BioPharma, Inc.'s Board of Directors, Effective December 31, 2022